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West Nile virus (WNV) is a neuro-tropic mosquito-borne flavivirus
responsible for recurrent outbreaks of
meningitis and encephalitis. Several stud-
ies analyzing the interactions of this path-
ogen with the autophagic pathway have
reported opposite results with evidence
for and against the upregulation of
autophagy in infected cells. In this
regard, we have recently reported that
minimal genetic changes (single amino
acid substitutions) in nonstructural pro-
teins of WNV can modify the ability of
the virus to induce autophagic features
such as LC3 modification and aggrega-
tion in infected cells. We think that these
results could help explain some of the
previously reported discrepancies. These
findings could also aid in deciphering the
interactions of this pathogen with the
autophagic pathway at the molecular
level aimed to develop feasible antiviral
strategies to combat this pathogen, and
other related flaviviruses.
West Nile virus, a neurotropic flavivi-
rus, is maintained in nature in an enzootic
infectious cycle between avian hosts and
ornithophilic mosquitoes.1 Since the virus
was first reported in the West Nile District
of Uganda in 1937, WNV circulation has
been associated with recurrent outbreaks
of meningitis and encephalitis affecting
humans and horses along different areas
of Africa, Europe, Asia, and Oceania. In
1999 the virus was detected for the first
time on the American continent in New
York (NY99 strain),2 and has spread
across the continent during the subse-
quent years. Nowadays, the virus has
become endemic in the USA, and is the
leading cause of epidemic encephalitis.3
Currently, there is no licensed vaccine or
therapy for human use against this
pathogen.
Macroautophagy (herein referred as
autophagy) is a catabolic mechanism that
sequesters cytoplasmatic components for
degradation.4 The autophagic pathway
can be upregulated to cope with diverse
forms of cellular stress, including viral
infections.5 In the case of flaviviruses, the
autophagic pathway can play multifaceted
roles during the infection of these patho-
gens that include rearrangements of cellu-
lar lipid metabolism, contribution to viral
maturation, or involvement in the early
steps of the infection.6–8 However,
whereas the upregulation of the autopha-
gic pathway has been well documented for
other flaviviruses (for a review see ref. 9),
the involvement of autophagy in WNV
infection has been controversial. There is
evidence supporting an upregulation of
autophagy upon WNV infection, mainly
based on the increase in the cellular con-
tent of the lipidated form of microtubule-
associated protein 1 light chain 3 (LC3)
and its aggregated forms visualized with
GFP-LC3 fusion constructs.10,11 How-
ever, there is also evidence showing that
infection by WNV does not induce the
lipidation of LC3, thus pointing to a lack
of upregulation of the autophagic pathway
in infected cells.12 Furthermore, these
reports also showed contradictory results
when the effect of the depletion of the
autophagy-related (ATG) protein ATG5,
a key regulator of autophagy, on the repli-
cation of WNV was analyzed. Whereas
Beatman et al.10 and Vandergaast and
Fredericksen12 noted that depletion of
ATG5 does not affect replication of
WNV, Kobayashi et al.11 reported that
WNV replication is increased in cells
depleted of this protein. One could think
that these opposing observations could be
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partially the result of different cell lines,
viruses, and methodologies used in these
studies. In fact, cell-type dependent differ-
ences or virus strain-dependent discrepan-
cies in the autophagic effect have been
reported for other viral models.13-15 How-
ever, a remarkable feature of the papers
addressing the specific case of WNV is
that autophagy analyses following infec-
tion with viruses from the NY99 genotype
lead to different results.10-12 We have
recently revisited the induction of autoph-
agy using a panel of WNV strains that var-
ied geographically and temporally,
including viruses belonging to the NY99
genotype. Our results showed that infec-
tion with all, except one, of the WNV
strains tested induce an increase in LC3
lipidation and aggregation of GFP-LC3
consistent with an upregulation of the
autophagic pathway.16 Remarkably, the
virus isolate that failed to induce autopha-
gic features was the NY99 strain17
included in the assays. Moreover, when a
persistent derivative of this parental NY99
strain isolated from a mouse 56 d after
vertical infection18 was tested, this virus
(termed mutant B13) also induced LC3
lipidation and aggregation, characteristics
of an upregulation of autophagy. The
complete genomic sequence of mutant
B13 showed only 2 nonsynonymous
nucleotide substitutions when compared
to its parental NY99 isolate. These nucleo-
tide substitutions are responsible for the
introduction of amino acid replacement
V67I in nonstructural protein 4A (NS4A)
and amino acid replacement I240M in
NS4B.16 Genetically engineered mutant
viruses carrying these mutations alone or
combined were constructed using an
infectious cDNA clone. The introduction
of any of these mutations in the recombi-
nant viruses is sufficient to promote an
increase in LC3 lipidation and aggregation
in comparison to the parental virus recov-
ered from the infectious cDNA clone.
These results confirmed that minimal
genetic changes in the NS proteins of
WNV can modulate the induction of
characteristic features of autophagy upre-
gulation in WNV-infected cells.
As noted above, our mutant B13,
which induces an increase in LC3 modifi-
cation/aggregation in comparison to its
parental isolate NY99, was isolated from a
persistently infected mouse.16 The persis-
tence of WNV in infected patients and
also in animal models has been well docu-
mented (for a review see ref. 19). Unfortu-
nately, the genomic sequence of the
viruses detected in most of these studies is
rather limited. Nevertheless, it has been
noted that WNV recovered from a persis-
tently infected hamster acquires different
mutations throughout the genome,
including in genes encoding NS pro-
teins.20 An attractive idea is that the selec-
tion of specific mutations could help in
the establishment of a persistent infection
in vivo. Supporting this idea of viral adap-
tation to persistent infections, in vitro
experiments using WNV replicons have
also shown that the selection of mutations
in NS proteins (including in NS4B) facili-
tates persistence.21 Following this reason-
ing, we examined whether the mutations
found in mutant B1316 are similar to
those observed in WNV recovered from
persistently infected hamster.20 The com-
parison of the sequences revealed that no
common mutations are selected in both
persistent viruses. The lack of common
mutations could reflect differences
between these WNV persistence models
and points to the flexibility of adaptation
of WNV. Anyway, the role of the muta-
tions selected in these persistent viruses
and their connections with the autophagic
pathway in vivo still remain to be fully
elucidated. However, it has to be also con-
sidered that the relationship between viral
persistent infections and autophagy has
been already documented in other viral
models.22,23 The specific case of hepatitis
C virus merits special consideration, since
this pathogen is also a member of the Fla-
viviridae family where WNV is classified.
This virus induces the selective degrada-
tion of mitochondria by autophagy
(mitophagy) that has been related to atten-
uation of viral apoptosis that contributes
to persistent infections.23 Hence, it is pos-
sible that the upregulation of the autopha-
gic pathway by mutant B13 could be
associated with the establishment of in
vivo persistence.
Nowadays, WNV stocks for laboratory
usage can be produced in cultured cells
from a limited number of infectious
clones available, and more commonly, by
amplification of diverse tissue culture-
adapted virus isolates. As with any RNA
virus, WNV has a high potential for muta-
tion and a relatively high degree of
sequence variation among viral isolates
occurs. In this way, closely related isolates,
even from the same genotype, exhibit dif-
ferences in the genomic sequence. These
differences do not only reflect sequence
differences in the source of the infectious
virus (infectious clone or isolate), but also
the selection of variants that have arisen
during the amplification of virus isolates
from different origins and passage history.
With these considerations in mind, we
think that the differences previously
observed in the studies analyzing the upre-
gulation or not of autophagy during
WNV infection could rely on genetic dif-
ferences of the viruses utilized in these
analyses. Thus, our results could help to
reconcile conflicting positions on the rela-
tionship between WNV and autophagy.
Regarding other flaviviruses, the ability to
induce LC3 modification and aggregation
has been reported to vary among different
strains of Japanese encephalitis virus,24
which also supports the idea that varia-
tions on the ability to upregulate the auto-
phagic pathway of the viral strains could
constitute a common feature of the
flaviviruses.
Albeit attractive, deciphering the
mechanism(s) behind the mutations in
NS4A and NS4B and the phenotype of
mutant viruses does not seem to be an
easy task, since these 2 proteins are multi-
functional transmembrane proteins that
have been involved in diverse aspects of
the flavivirus life cycle. NS4A has been
related to WNV-induced intracellular
membrane rearrangements and the mech-
anisms to overcome superinfection exclu-
sion.25,26 In the case of Dengue virus
(another flavivirus) the expression of
NS4A has been also related to evasion of
the innate immune response and protec-
tion against cell death through induction
of autophagy.27,28 On the other hand,
NS4B has been associated with flavivirus-
induced membrane rearrangements, RNA
synthesis, and evasion of innate immu-
nity.27,29,30 In fact, a WNV mutant carry-
ing a single amino acid substitution in
NS4B is attenuated and induces strong
innate and adaptative immune responses
in vivo.31 Moreover, the expression of
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both NS4A and NS4B in WNV-infected
cells has also been associated with the acti-
vation of the unfolded protein response,
another cellular stress pathway.32 All these
findings suggest that NS4A and NS4B
play central roles in the connections
between virus replication, membrane rear-
rangements, autophagy, and immune
response in WNV-infected cells. Consis-
tent with this view, these 2 proteins could
constitute interesting antiviral targets
against WNV and other related
flaviviruses.
In our experiments, the viruses induc-
ing different autophagic features share
common growth kinetics in cultured
cells.16 This apparent lack of effect of
autophagy on in vitro replication of
WNV is consistent with the results
obtained by other researchers when
autophagy-related proteins are depleted in
cultured cells.10,12 However, Kobayashi
et al.11 observed that autophagy-deficient
cells (atg5¡/¡ MEFs) display an increase
in virus replication relative to control cells
(Atg5C/C MEFs). This increase in virus
replication correlates also with an increase
in virus yield when a very low infection
dose is used. Based on these observations
these authors suggested a protective role of
autophagy against WNV infection. This
could be consistent with the reported pro-
tective role of autophagy against infection
with other arboviruses.33,34 In fact, exoge-
nous activation of autophagy by a proau-
tophagic peptide results in protection
against WNV infection in vivo and consti-
tutes a promising antiviral strategy.35
Along this line, we must remember that
the mutant virus differing in autophagy
upregulation was isolated from a persis-
tently infected mouse, which might indi-
cate that autophagy plays a role during in
vivo infection with WNV, regardless of
the results observed in vitro. Considering
that the relationship between autophagy
and viral persistence has been docu-
mented,22,23 and that persistent infections
have to cope with the immune system of
the host in a more prolonged way than
during acute infections, the immunologi-
cal role of autophagy during WNV infec-
tion in vivo becomes patent. In any case,
this does not exclude the possibility that
autophagy could play other relevant roles
not yet assessed during WNV infection.
Thus, deciphering the interactions
between WNV with the autophagic path-
way through in vivo experiments, could
help with the development of novel antivi-
ral strategies to combat this pathogen.
Further in vitro and in vivo characteriza-
tion of these novel mutants differing in
their ability to induce LC3 modification/
aggregation, together with the analysis of
more genetically divergent viral strains,
could provide new clues to understand the
molecular mechanisms behind the upre-
gulation of autophagy in WNV-infected
cells.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were
disclosed.
Funding
This work was funded by INIA
(RTA2011-0036 and E-RTA2013-
00013-C01) and the Comunidad
Autonoma de Madrid PLATESA (P2013/
ABI-2906). MAMA received a postdoc-
toral fellowship JAE-Doc from CSIC.
References
1. Martin-Acebes MA, Saiz JC. West Nile virus: a re-
emerging pathogen revisited. World J Virol 2012;
1:51–70; PMID:24175211; http://dx.doi.org/10.5501/
wjv.v1.i2.51
2. Lanciotti RS, Roehrig JT, Deubel V, Smith J, Parker
M, Steele K, Crise B, Volpe KE, Crabtree MB, Scherret
JH, et al. Origin of the West Nile virus responsible for
an outbreak of encephalitis in the northeastern United
States. Science 1999; 286:2333–7; PMID:10600742;
http://dx.doi.org/10.1126/science.286.5448.2333
3. Roehrig JT.West nile virus in the United States - a histori-
cal perspective. Viruses 2013; 5:3088–108;
PMID:24335779; http://dx.doi.org/10.3390/v5123088
4. Mizushima N, Levine B, Cuervo AM, Klionsky DJ.
Autophagy fights disease through cellular self-digestion.
Nature 2008; 451:1069–75; PMID:18305538; http://
dx.doi.org/10.1038/nature06639
5. Jordan TX, Randall G. Manipulation or capitulation:
virus interactions with autophagy. Microbes Infect
2012; 14:126–39; PMID:22051604; http://dx.doi.org/
10.1016/j.micinf.2011.09.007
6. Heaton NS, Randall G. Dengue virus-induced autoph-
agy regulates lipid metabolism. Cell Host Microbe
2010; 8:422–32; PMID:21075353; http://dx.doi.org/
10.1016/j.chom.2010.10.006
7. Mateo R, Nagamine CM, Spagnolo J, Mendez E, Rahe
M, Gale M, Jr., Yuan J, Kirkegaard K. Inhibition of cellu-
lar autophagy deranges dengue virion maturation. Journal
of virology 2013; 87:1312–21; PMID:23175363; http://
dx.doi.org/10.1128/JVI.02177-12
8. Panyasrivanit M, Khakpoor A, Wikan N, Smith DR.
Linking dengue virus entry and translation/replication
through amphisomes. Autophagy 2009; 5:434–5;
PMID:19202356; http://dx.doi.org/10.4161/auto.
5.3.7925
9. Blazquez AB, Escribano-Romero E, Merino-Ramos T,
Saiz JC, Martin-Acebes MA. Stress responses in flavivi-
rus-infected cells: activation of unfolded protein
response and autophagy. Front Microbiol 2014; 5:266;
PMID:24917859; http://dx.doi.org/10.3389/fmicb.
2014.00266
10. Beatman E, Oyer R, Shives KD, Hedman K, Brault
AC, Tyler KL, David Beckham J. West Nile virus
growth is independent of autophagy activation. Virol-
ogy 2012; 433:262–72; PMID:22939285; http://dx.
doi.org/10.1016/j.virol.2012.08.016
11. Kobayashi S, Orba Y, Yamaguchi H, Takahashi K,
Sasaki M, Hasebe R, Kimura T, Sawa H. Autophagy
inhibits viral genome replication and gene expression
stages in West Nile virus infection. Virus Res 2014;
191:83–91; PMID:25091564; http://dx.doi.org/
10.1016/j.virusres.2014.07.016
12. Vandergaast R, Fredericksen BL. West Nile virus
(WNV) replication is independent of autophagy in
mammalian cells. PloS One 2012; 7:e45800;
PMID:23029249; http://dx.doi.org/10.1371/journal.
pone.0045800
13. Cavignac Y, Esclatine A. Herpesviruses and autophagy:
catch me if you can! Viruses 2010; 2:314–33;
PMID:21994613; http://dx.doi.org/10.3390/v2010314
14. Tang SW, Ducroux A, Jeang KT, Neuveut C. Impact
of cellular autophagy on viruses: Insights from hepatitis
B virus and human retroviruses. J Biomed Sci 2012;
19:92; PMID:23110561; http://dx.doi.org/10.1186/
1423-0127-19-92
15. Dumit VI, Dengjel J. Autophagosomal protein dynam-
ics and influenza virus infection. Front Immunol 2012;
3:43; PMID:22566925; http://dx.doi.org/10.3389/
fimmu.2012.00043
16. Blazquez AB, Martin-Acebes MA, Saiz JC. Amino acid
substitutions in the non-structural proteins 4A or 4B
modulate the induction of autophagy in West Nile
virus infected cells independently of the activation of
the unfolded protein response. Front Microbiol 2015;
5:797; PMID:25642225; http://dx.doi.org/10.3389/
fmicb.2014.00797
17. Martin-Acebes MA, Saiz JC. A West Nile virus mutant
with increased resistance to acid-induced inactivation. J
Gen Virol 2011; 92:831–40; PMID:21228127; http://
dx.doi.org/10.1099/vir.0.027185-0
18. Blazquez AB, Saiz JC. West Nile virus (WNV) trans-
mission routes in the murine model: intrauterine, by
breastfeeding and after cannibal ingestion. Virus
research 2010; 151:240–3; PMID:20438776; http://
dx.doi.org/10.1016/j.virusres.2010.04.009
19. Garcia MN, Hasbun R, Murray KO. Persistence of
West Nile virus. Microb Infect 2015; 17:163–8;
PMID:25499188; http://dx.doi.org/10.1016/j.
micinf.2014.12.003
20. Wu X, Lu L, Guzman H, Tesh RB, Xiao SY. Persistent
infection and associated nucleotide changes of West
Nile virus serially passaged in hamsters. J Gen Virol
2008; 89:3073–9; PMID:19008395; http://dx.doi.org/
10.1099/vir.0.2008/003210-0
21. Rossi SL, Fayzulin R, Dewsbury N, Bourne N, Mason
PW. Mutations in West Nile virus nonstructural pro-
teins that facilitate replicon persistence in vitro attenu-
ate virus replication in vitro and in vivo. Virology
2007; 364:184–95; PMID:17382364; http://dx.doi.
org/10.1016/j.virol.2007.02.009
22. E X, Hwang S, Oh S, Lee JS, Jeong JH, Gwack Y,
Kowalik TF, Sun R, Jung JU, Liang C. Viral Bcl-2-
mediated evasion of autophagy aids chronic infection of
gammaherpesvirus 68. PLoS Pathog 2009; 5:
e1000609; PMID:19816569; http://dx.doi.org/
10.1371/journal.ppat.1000609
23. Kim SJ, Syed GH, Khan M, Chiu WW, Sohail MA,
Gish RG, Siddiqui A. Hepatitis C virus triggers mito-
chondrial fission and attenuates apoptosis to promote
viral persistence. Proc Natl Acad Sci U S A 2014;
111:6413–8; PMID:24733894; http://dx.doi.org/
10.1073/pnas.1321114111
www.tandfonline.com 863Autophagy
24. Li JK, Liang JJ, Liao CL, Lin YL. Autophagy is involved
in the early step of Japanese encephalitis virus infection.
Microb Infect 2012; 14:159–68; PMID:21946213;
http://dx.doi.org/10.1016/j.micinf.2011.09.001
25. Roosendaal J, Westaway EG, Khromykh A, Mackenzie
JM. Regulated cleavages at theWest Nile virus NS4A-2K-
NS4B junctions play a major role in rearranging cyto-
plasmic membranes and Golgi trafficking of the NS4A
protein. J Virol 2006; 80:4623–32; PMID:16611922;
http://dx.doi.org/10.1128/JVI.80.9.4623-4632.2006
26. Campbell CL, Smith DR, Sanchez-Vargas I, Zhang B,
Shi PY, Ebel GD. A positively selected mutation in the
WNV 2K peptide confers resistance to superinfection
exclusion in vivo. Virology 2014; 464–465:228–32;
PMID:25104615
27. Munoz-Jordan JL, Sanchez-Burgos GG, Laurent-Rolle
M, Garcia-Sastre A. Inhibition of interferon signaling
by dengue virus. Proc Natl Acad Sci U S A 2003;
100:14333–8; PMID:14612562; http://dx.doi.org/
10.1073/pnas.2335168100
28. McLean JE, Wudzinska A, Datan E, Quaglino D,
Zakeri Z. Flavivirus NS4A-induced autophagy protects
cells against death and enhances virus replication. J Biol
Chem 2012; 286:22147–59; PMID:21511946; http://
dx.doi.org/10.1074/jbc.M110.192500
29. Puig-Basagoiti F, Tilgner M, Bennett CJ, Zhou Y,
Munoz-Jordan JL, Garcia-Sastre A, Bernard KA, Shi
PY. A mouse cell-adapted NS4B mutation attenuates
West Nile virus RNA synthesis. Virology 2007;
361:229–41; PMID:17178141; http://dx.doi.org/
10.1016/j.virol.2006.11.012
30. Kaufusi PH, Kelley JF, Yanagihara R, Nerurkar VR.
Induction of endoplasmic reticulum-derived replica-
tion-competent membrane structures by West Nile
virus non-structural protein 4B. PloS One 2014; 9:
e84040; PMID:24465392; http://dx.doi.org/10.1371/
journal.pone.0084040
31. Welte T, Xie G, Wicker JA, Whiteman MC, Li L,
Rachamallu A, Barrett A, Wang T. Immune responses
to an attenuated West Nile virus NS4B-P38G mutant
strain. Vaccine 2011; 29:4853–61; PMID:21549792;
http://dx.doi.org/10.1016/j.vaccine.2011.04.057
32. Ambrose RL, Mackenzie JM. West Nile virus differen-
tially modulates the unfolded protein response to
facilitate replication and immune evasion. J Virol 2011;
85:2723–32; PMID:21191014; http://dx.doi.org/
10.1128/JVI.02050-10
33. Joubert PE, Werneke SW, de la Calle C, Guivel-Ben-
hassine F, Giodini A, Peduto L, Levine B, Schwartz O,
Lenschow DJ, Albert ML. Chikungunya virus-induced
autophagy delays caspase-dependent cell death. J Exp
Med 2012; 209:1029–47; PMID:22508836; http://dx.
doi.org/10.1084/jem.20110996
34. Orvedahl A, MacPherson S, Sumpter R, Jr., Talloczy Z,
Zou Z, Levine B. Autophagy protects against Sindbis
virus infection of the central nervous system. Cell Host
Microbe 2012; 7:115–27; PMID:20159618; http://dx.
doi.org/10.1016/j.chom.2010.01.007
35. Shoji-Kawata S, Sumpter R, Leveno M, Campbell GR,
Zou Z, Kinch L, Wilkins AD, Sun Q, Pallauf K, MacDuff
D, et al. Identification of a candidate therapeutic autoph-
agy-inducing peptide. Nature 2013; 494:201–6;
PMID:23364696; http://dx.doi.org/10.1038/nature11866
864 Volume 11 Issue 5Autophagy
